Cargando…
Pre-silencing of genes involved in the electron transport chain (ETC) pathway is associated with responsiveness to abatacept in rheumatoid arthritis
BACKGROUND: In the current context of personalized medicine, one of the major challenges in the management of rheumatoid arthritis (RA) is to identify biomarkers that predict drug responsiveness. From the European APPRAISE trial, our main objective was to identify a gene expression profile associate...
Autores principales: | Derambure, C., Dzangue-Tchoupou, G., Berard, C., Vergne, N., Hiron, M., D’Agostino, M. A., Musette, P., Vittecoq, O., Lequerré, T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5445375/ https://www.ncbi.nlm.nih.gov/pubmed/28545499 http://dx.doi.org/10.1186/s13075-017-1319-8 |
Ejemplares similares
-
Gene expression regulated by abatacept associated with methotrexate and correlation with disease activity in rheumatoid arthritis
por: Derambure, Céline, et al.
Publicado: (2020) -
Dysregulation of RasGRP1 in rheumatoid arthritis and modulation of RasGRP3 as a biomarker of TNFα inhibitors
por: Golinski, Marie-Laure, et al.
Publicado: (2015) -
Gene profiling in white blood cells predicts infliximab responsiveness in rheumatoid arthritis
por: Lequerré, Thierry, et al.
Publicado: (2006) -
Early and long-standing rheumatoid arthritis: distinct molecular signatures identified by gene-expression profiling in synovia
por: Lequerré, Thierry, et al.
Publicado: (2009) -
Abatacept in the treatment of rheumatoid arthritis
por: Buch, Maya H, et al.
Publicado: (2008)